SEHA Begin Administering Sinopharm Covid-19 Vaccines To Children Aged 3 To 17 Years Old

Press release

Published August 4th, 2021 - 02:43 GMT

SEHA Begin Administering Sinopharm Covid-19 Vaccines To Children Aged 3 To 17 Years Old

SEHA HealthSystem.

Highlights

Abu Dhabi Health Services Company, (SEHA), announced its provision of Sinopharm’s COVID-19 vaccine to children aged 3 to 17 in centers and facilities across its network, available for walk-ins.

Abu Dhabi Health Services Company, (SEHA), announced its provision of Sinopharm’s COVID-19 vaccine to children aged 3 to 17 in centers and facilities across its network, available for walk-ins. This announcement follows the Ministry of Health & Prevention’s (MOHAP) approval for emergency use based on the clinical trials and local evaluations.

The Pfizer vaccine will continue being administered for aged 12 years old and over, as normal.

For more information, members of the community are encouraged to call 800 50 or visit https://www.seha.ae/covid-19-landing/.

Background Information

SEHA HealthSystem

SEHA is the corporate marketing name of Abu Dhabi Health Services Company, an independent public joint stock company that owns and operates all public hospitals and clinics across the emirate. ‘SEHA’ is a phonetic rendering of the Arabic word for health.

The company was established by Emiri Decree No 10 of 2007 and is a leading participant in the reform of Abu Dhabi’s healthcare sector. The reform seeks to upgrade and improve healthcare delivery to the public at a level comparable to the finest healthcare systems in the world. The program began by separating management and regulation – SEHA assumed responsibility for public healthcare centers and hospitals, while Health Authority-Abu Dhabi (HA-AD) was established to regulate the public and private sectors. The two organizations replaced the General Authority for Health Services (GAHS), previously responsible for both roles.